PubRank

Grazia D'Onofrio

Author PubWeight™ 21.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J Alzheimers Dis 2010 1.23
2 The Multidimensional Prognostic Index (MPI), based on a comprehensive geriatric assessment predicts short- and long-term mortality in hospitalized older patients with dementia. J Alzheimers Dis 2009 1.16
3 The multidimensional prognostic index predicts short- and long-term mortality in hospitalized geriatric patients with pneumonia. J Gerontol A Biol Sci Med Sci 2009 1.15
4 Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option? Expert Opin Investig Drugs 2011 1.04
5 Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease. Ageing Res Rev 2009 0.98
6 Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab. Curr Alzheimer Res 2011 0.93
7 Information and communication technology systems to improve quality of life and safety of Alzheimer's disease patients: a multicenter international survey. J Alzheimers Dis 2011 0.92
8 The RELN locus in Alzheimer's disease. J Alzheimers Dis 2008 0.91
9 The genetics of the human APOE polymorphism. Rejuvenation Res 2011 0.91
10 A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack. J Neurol 2011 0.90
11 The Comprehensive Geriatric Assessment and the multidimensional approach. A new look at the older patient with gastroenterological disorders. Best Pract Res Clin Gastroenterol 2009 0.88
12 Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. Ageing Res Rev 2011 0.85
13 Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene. Int J Alzheimers Dis 2011 0.81
14 Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease. Immunotherapy 2010 0.81
15 Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease. Neurosci Lett 2008 0.80
16 TOMM40, APOE, and APOC1 in primary progressive aphasia and frontotemporal dementia. J Alzheimers Dis 2012 0.78
17 Klotho locus, metabolic traits, and serum hemoglobin in hospitalized older patients: a genetic association analysis. Age (Dordr) 2011 0.78
18 Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia. Dement Geriatr Cogn Disord 2010 0.77
19 Treatment of late-life major depressive disorder with selective serotonin reuptake inhibitors improves the multidimensional prognostic index. J Clin Psychopharmacol 2012 0.77
20 Angiotensin-converting enzyme (ACE) genotypes and disability in hospitalized older patients. Age (Dordr) 2010 0.77
21 Association of apolipoprotein E and angiotensin converting enzyme gene polymorphisms with the multidimensional impairment in older patients. Rejuvenation Res 2009 0.76
22 Neuroprotective Effects of Quercetin: From Chemistry to Medicine. CNS Neurol Disord Drug Targets 2016 0.76
23 Apolipoprotein E-related all-cause mortality in hospitalized elderly patients. Age (Dordr) 2010 0.75
24 Pharmacogenetics in older people: what we know and what we need to know. J Nephrol 2012 0.75
25 Effectiveness of a high-throughput genetic analysis in the identification of responders/non-responders to CYP2D6-metabolized drugs. Clin Lab 2011 0.75
26 The serotonin transporter gene locus in late-life major depressive disorder. Am J Geriatr Psychiatry 2013 0.75